Vijay Koya,Bryan Allen Clark,Keith R. Maile,Michael J. Kane,Jeffrey E. Stahmann,Elizabeth Mary Annoni
申请号：
US16732796
公开号：
US20200215266A1
申请日:
2020.01.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A system may include an input device configured to receive a signal indicative of elevated glucose in a patient, and an electrical stimulator configured to electrically stimulate at least one skeletal muscle. The system may further include a controller operably connected to the electrical stimulator. The controller may be configured for delivering a glucose therapy in response to the signal by controlling the electrical stimulator. The system may be configured to deliver the therapy in combination with other glucose therapies, and the therapy may be titrated based on a sensed parameter or patient feedback.
